CC
MD icon

Caspian Capital’s Pediatrix Medical MD Stock Holding History

Caspian Capital’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$12.9M Buy
1,115,000
+665,000
+148% +$6.27M 17.61% 2
2024
Q2 		$3.4M Buy
+450,000
New +$3.72M 6.13% 4

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Caspian Capital's MD Position: Q3 2024 in Review

Caspian Capital increased its Pediatrix Medical (MD) stake by 148% in Q3 2024, buying an estimated $6.27M and bringing the position to 1,115,000 shares worth $12.9M. The position accounts for 17.61% of the portfolio, ranked #2.

Caspian Capital first reported a position in MD in Q2 2024 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

  • Caspian Capital held 1,115,000 shares of Pediatrix Medical worth $12.9M as of Q3 2024.
  • Caspian Capital bought 665,000 Pediatrix Medical shares in Q3 2024, an estimated $6.27M.
  • Pediatrix Medical made up 17.61% of Caspian Capital's portfolio in Q3 2024, its #2 holding.
  • Caspian Capital first reported a position in Pediatrix Medical in Q2 2024 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on Caspian Capital's 13F filing for Q3 2024, filed 14 Nov 2024.